MAC 2000 algorithm

Since the introduction of the Marquette* 12SL ECG analysis program in 1980, GE Healthcare has consistently expanded its electrocardiograph-based suite of ECG analysis programs and capabilities. Our commitment to improving the science of ECG interpretation has led to the use of our analysis programs across GE diagnostic ECG and monitoring systems, as well as implementation into other industry-leading products.

Clinically validated improvements

Any change to an analysis program requires a great deal of research and validation. The Marquette 12SL ECG analysis program is continually refined through:

Regular clinical input
Clinically correlated “Gold Standard” databases
Beyond “Gold Standard” databases

A complete suite of state-of-the-art ECG analysis

With the Marquette 12SL’s arrhythmia and chest pain assessment capabilities, gender-specific criteria and risk stratification tools, a wider range of disease management needs can be addressed.

Serial ECG comparison - The Marquette 12SL ECG Analysis Program and the Marquette Serial Comparison Program provide a consistent analysis and comparison of waveforms across each and every ECG, helping to ensure reproducibility and objectivity through all phases of patient care.
Gender-Specific criteria – Marquette 12SL with Gender-Specific interpretation applies criteria for evaluating the ST segment and T wave of the ECG waveform, improving sensitivity to acute myocardial infarction in women and enhancing diagnostic confidence.
Experience in QT measurement accuracy
Analysis of Artificially–Paced Rhythms
Acute Coronary Syndrome Tool – The 12SL ACS tool provides higher-sensitivity analysis for ST-Elevated MI or Acute Ischemia for patients suspected of having an acute cardiac event